Construction of pharmacophore model of PARP-1 inhibitor / 药学学报
Acta Pharmaceutica Sinica
;
(12): 279-285, 2007.
Artículo
en Chino
| WPRIM
| ID: wpr-281907
ABSTRACT
To construct the pharmacophore model of the poly (ADP-ribose) polymerase-1 inhibitor and to investigate the possible inhibitory mechanisms, ten pharmacophore models of PARP-1 inhibitor were established from the training set of thirty-eight PARP-1 inhibitors with conformer analysis and pharmacophore mapping by using the Catalyst software. Based on the mechanism of action and the known structure-activity relationship of PARP-1 inhibitor, an optimal pharmacophore model including two hydrogen-bonding acceptors and two aromatic hydrophobic core was confirmed. The reliability of the optimal pharmacophore model is preferably with RMS = 0.46, Correl = 0.91, Weight = 2.06, and Config = 15.97. This pharmacophore model not only provided some information about the interaction between enzyme and compound, but also showed excellent forecast ability and contributes to design the PARP-1 inhibitors with undiscovered structure.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Farmacología
/
Conformación Proteica
/
Diseño de Fármacos
/
Estructura Molecular
/
Modelos Moleculares
/
Química
/
Poli(ADP-Ribosa) Polimerasas
/
Diseño Asistido por Computadora
/
Inhibidores Enzimáticos
/
Inhibidores de Poli(ADP-Ribosa) Polimerasas
Idioma:
Chino
Revista:
Acta Pharmaceutica Sinica
Año:
2007
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS